Equities Analysts Set Expectations for Teleflex Q4 Earnings

Teleflex Incorporated (NYSE:TFX) – Needham & Company LLC dropped their Q4 2025 EPS estimates for shares of Teleflex in a report released on Tuesday, January 27th. Needham & Company LLC analyst M. Matson now forecasts that the medical technology company will post earnings per share of $3.65 for the quarter, down from their previous forecast of $3.80. Needham & Company LLC has a “Buy” rating and a $138.00 price objective on the stock. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share.

Other analysts also recently issued research reports about the stock. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research report on Monday, December 29th. Wells Fargo & Company boosted their price target on shares of Teleflex from $114.00 to $139.00 and gave the company an “equal weight” rating in a report on Wednesday, December 10th. Truist Financial upped their price target on Teleflex from $120.00 to $135.00 and gave the stock a “hold” rating in a research note on Thursday, December 18th. Royal Bank Of Canada restated a “sector perform” rating and issued a $135.00 price target on shares of Teleflex in a research report on Wednesday, December 17th. Finally, Wall Street Zen downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $141.88.

Teleflex Price Performance

NYSE:TFX opened at $105.33 on Thursday. The company has a current ratio of 2.57, a quick ratio of 1.53 and a debt-to-equity ratio of 0.67. The firm has a market cap of $4.65 billion, a price-to-earnings ratio of -14.33, a price-to-earnings-growth ratio of 1.36 and a beta of 0.93. The company’s 50-day moving average is $116.20 and its two-hundred day moving average is $119.73. Teleflex has a 12-month low of $100.18 and a 12-month high of $184.58.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, beating the consensus estimate of $3.38 by $0.29. The firm had revenue of $892.90 million during the quarter, compared to the consensus estimate of $892.79 million. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. Teleflex’s revenue for the quarter was up 19.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.49 EPS. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS.

Institutional Investors Weigh In On Teleflex

A number of large investors have recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB lifted its stake in Teleflex by 57.9% during the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock worth $26,000 after purchasing an additional 77 shares during the last quarter. Hantz Financial Services Inc. grew its holdings in shares of Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after purchasing an additional 199 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in Teleflex in the 3rd quarter valued at approximately $35,000. True Wealth Design LLC boosted its stake in shares of Teleflex by 10,333.3% in the 2nd quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock valued at $37,000 after purchasing an additional 310 shares during the last quarter. Finally, V Square Quantitative Management LLC acquired a new position in Teleflex in the fourth quarter valued at $37,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Friday, November 14th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date was Friday, November 14th. Teleflex’s payout ratio is presently -18.50%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.